Search

Search Constraints

You searched for: Author/Creator Takamura, Kei

Search Results

2. A Phase II Study of Amrubicin as a Third‐Line or Fourth‐Line Chemotherapy for Patients With Non‐Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901. (26th February 2013)

3. A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302). (December 2019)

4. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702). (8th May 2019)

5. Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004). (March 2021)

6. Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival. Issue 7 (July 2020)

7. Multi‐institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases. Issue 5 (31st March 2015)

8. Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902). (June 2021)

9. Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A). Issue 3 (December 2015)

10. Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer. (1st January 2021)